NASDAQ:SPNE
Delisted
SeaSpine Holdings Corporation Stock News
$9.54
+0 (+0%)
At Close: Apr 03, 2023
SeaSpine Announces Publication of Results from a Cellular Bone Graft Study in The Journal of Bone and Joint Surgery (JBJS)
08:00am, Tuesday, 03'rd Nov 2020
Study shows cells in cellular bone matrix products did not improve fusion SeaSpine's DBM outperformed the tested CBM products Study shows cells in cellular bone matrix products did not improve fusion
SeaSpine to Report Third Quarter 2020 Financial Results on November 9, 2020
04:05pm, Tuesday, 27'th Oct 2020
CARLSBAD, Calif., Oct. 27, 2020 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorder
